Clinical Sales Specialist (CS) - Kendall, FL jobs in United States
cer-icon
Apply on Employer Site
company-logo

Corcept Therapeutics · 1 day ago

Clinical Sales Specialist (CS) - Kendall, FL

positionFlorida, United States
timeFull-time
remoteOnsite
senioritySenior Level
money$140K/yr - $155K/yr
date5+ years exp

Corcept Therapeutics is leading the way in the research and development of cortisol modulators. The Clinical Sales Specialist is accountable for implementing sales strategies for approved products, building relationships with healthcare providers, and managing territory plans to enhance brand loyalty.

BiotechnologyMedicalPharmaceutical
check
Comp. & Benefits

Responsibilities

Build and develop professional relationships with influential high prescribers and thought leaders in the territory to enhance Corcept brand and product loyalty
Leverages expertise and knowledge of the therapeutic disease state, the marketplace, applicable competitors, industry, and cross-functional activities/plans to anticipate and effectively manage business opportunities and challenges
Develops and implements effective customer specific territory plans and communicates insights to internal stakeholders
Prioritizes time and effort to ensure optimal coverage of appropriate physician specialists based on opportunity and potential
Plan and participate in education programs and speaker dinner programs
Manage territory expenses/budget to support sales and marketing activities

Qualification

Sales experienceEndocrine relationshipsCustomer territory planningCross-functional collaborationHigh performance track record

Required

BA/BS or equivalent work experience
5+ years sales experience required
Required to travel up to 100% of the time, including up to 40% overnight travel
Must maintain a driving record in accordance with Corcept vehicle policy
Able to lift and/or move up to 35 pounds

Preferred

Proven track record of consistent high performance
Strong ability to collaborate and work cross-functionally
Recent endocrine relationships, specialty therapeutic, hospital, or orphan drugs sales experience highly preferred

Company

Corcept Therapeutics

twittertwittertwitter
company-logo
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
dateFounded in 1998
location
Menlo Park, California, USA
people-size501-1000 employees
web-link
http://www.corcept.com

Funding

Current Stage
Public Company
Total Funding
$119.09M
Key Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M

Leadership Team

leader-logo
Roberto Vieira
President, Oncology
linkedin
leader-logo
Yuan Xu
Associate Director, Statistical Programming
linkedin

Recent News

legacy.thefly.com
Corcept Therapeutics reports ROSELLA trial meets primary endpoint
2026-01-23
Morningstar.com
CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm
2026-01-22
Benzinga.com
Corcept Therapeutics Experimental Lead Drug Cuts Death Risk By 35% In Advanced Ovarian Cancer Patients, Stock Jumps
2026-01-22
Company data provided by crunchbase